Doula Threshold — The Week in Maternal-Pediatric Health Tech

Partum Health — $3.1M Seed + University of Chicago Medicine Partnership

Partum Health, a Chicago-based full-spectrum doula and maternal support platform, raised $3.1 million led by MAGIC Fund — with The Fund Midwest, Tawani Ventures, Bridge Ventures, and Pioneer Healthcare Partners participating — and simultaneously launched the first 24/7 hospital-embedded doula program at a major academic medical center in Illinois. At UChicago Medicine's Family Birth Center in Hyde Park, a team of Partum doulas now works around the clock alongside physicians and midwives, available to all laboring patients without pre-arrangement. The structural shift here is significant: this converts doula care from a consumer product families must independently source into a hospital-staffed clinical role, bundled into the delivery experience — a go-to-market model that positions institutional B2B contracts, not consumer marketplace matching, as the scalable path. Hyde Park is a majority-Black South Side community with some of Illinois's highest maternal mortality rates; the health equity implications of this deployment, combined with Illinois Medicaid's recent doula reimbursement expansion, create a replicable template for other health systems.

UnitedHealthcare — Doula Benefit Expansion to 7.2 Million Employer Members

UnitedHealthcare is expanding its doula support benefit — structured through a partnership with The Doula Network — to employer-sponsored health plans nationwide, with up to 7.2 million members potentially gaining access by January 1, 2027. The benefit covers prenatal visits, continuous in-person labor support, and 24/7 on-call support from 37 weeks through birth, alongside a parallel Medicaid pilot already live in six states. The clinical data UHC is citing should accelerate this category's adoption across every major payer: members who received 3+ doula visits saw 50% lower preterm birth rates, 58% fewer low-birth-weight infants, and 35% lower NICU utilization. Those are not marginal improvements — they are numbers that move an actuary. The open strategic question for Flourish Care, Partum Health, Malama Health, and every other doula platform startup: does UHC's exclusive Doula Network partnership create a distribution ceiling, or is there room for employer benefit-embedded platforms alongside it?

Keriton + TheraB Medical — Natus Sensory's NICU Acquisition Sprint

Natus Sensory acquired Keriton (Philadelphia, cloud-based NICU feeding safety and breast milk management) on January 28 and TheraB Medical (maker of SnugLit, the first FDA-cleared wearable swaddle-style phototherapy device for neonatal jaundice) on February 11 — two acquisitions in 14 days, both undisclosed terms. Combined with AngelEye Health's acquisition of the SupportSpot psychosocial platform from Child Life On Call on March 25, that's three NICU/neonatal acquisitions in under 90 days from companies that already operate in the space. Natus's existing portfolio — hearing screening, jaundice phototherapy, NicView video monitoring, Neometrics case management — now adds feeding management software and a wearable therapeutic device, sketching the outline of an integrated neonatal care bundle that competes against the fragmented point-solution landscape health systems are currently navigating. The pace of M&A suggests Natus knows exactly what it's building.

Grow Therapy — $150M Series D (TCV + Goldman Sachs, $3B valuation)

Grow Therapy closed a $150 million Series D led by TCV and Goldman Sachs Alternatives Growth Equity, with BCI and Menlo Ventures joining existing backers Sequoia, SignalFire, and Transformation Capital. The round values the company at $3 billion on more than $1 billion in annual revenue and 7 million visits in 2025 — a unit economics story that justifies the valuation on its own. Grow serves children and adolescents ages 6+ through its 26,000-provider network across 125+ health plan partnerships covering 220 million Americans, and its newly announced EAP-to-insurance transition feature addresses one of behavioral health's most persistent access barriers. In isolation, this is a generalist behavioral health story. In context — with Talkiatry ($210M, February), Salma Health ($80M, March), and Grow Therapy together representing nearly $460M in Q1 behavioral health raises — it signals a renewal of institutional conviction in scaled behavioral health infrastructure that will pull capital toward the more specialized pediatric and adolescent platforms underneath it.

Carrot Fertility + Blueberry Pediatrics — On-Demand Pediatric Telehealth in Employer Benefits

Carrot Fertility is embedding 24/7 on-demand pediatric telehealth into its family-building benefits platform through a partnership with Blueberry Pediatrics, giving Carrot members with children under 12 access to board-certified pediatricians via video — plus a home diagnostic kit including a wireless digital ear scope, pulse oximeter, and thermometer. The partnership is rolling out to Carrot members in spring 2026. The strategic logic is a direct extension of the continuum thesis: fertility benefits platforms that stop at birth leave significant member lifetime value on the table. Carrot is now following the member from pre-conception through early parenting; Blueberry gets employer distribution without consumer acquisition cost. Every fertility and maternity benefits platform — Maven, Progyny, Ovia — is watching this move and running the same calculation.

OBBBA Medicaid Cuts: Six Months to October, and the Maternal Health Countdown Is On

The Medicaid provisions of the One Big Beautiful Bill Act — signed July 4, 2025 — reach their most consequential implementation milestones in October 2026: new work and reporting requirements for able-bodied adults, more frequent eligibility redeterminations, and restrictions on Medicaid eligibility for many lawfully present immigrants. A Georgetown Center for Children and Families report released April 1 adds state-level specificity to the risk picture, documenting which states' pregnant and postpartum women face the greatest coverage exposure. The CBO projects 7.8 million people will become uninsured under these provisions. For maternal and pediatric health startups, two forces now run in opposite directions simultaneously: the doula Medicaid reimbursement expansion that reached 30+ states in four years faces rollback risk as state budgets tighten, while the coverage gaps the cuts create accelerate demand for employer-channel alternatives. Companies with dual payer-channel models — able to serve both Medicaid families and commercially insured employer populations — are structurally better positioned than those that bet on one channel.

CMS ASPIRE Model: $125M for Complex Pediatric Medicaid Care, ACO-Style

CMS announced the ASPIRE (Accelerating State Pediatric Innovation Readiness and Effectiveness) Model on March 24 — a 10-year, voluntary state program funding whole-person care for Medicaid and CHIP enrollees up to age 21 with complex medical and/or behavioral needs. Up to five states will receive grants from a $125 million pool; a Notice of Funding Opportunity is expected later in 2026. The program requirements — single care coordinator per family, 24/7 medical advice with full clinical context, joint physical and behavioral health management — describe what Imagine Pediatrics and Brightline already do. That is the point: ASPIRE creates a structured reimbursement pathway for the care model that pediatric complex care companies have been building under Medicaid managed care contracts. When CMS releases the NOFO, state RFPs will follow — and the companies that have deployment infrastructure and outcome data in complex pediatric care will have a significant advantage over anyone trying to build to the specification from scratch.

That's your Tuesday roundup. Thursday's deep dive: The Medicaid foundation that built the doula category is about to shift — and the companies that positioned themselves in the employer channel may have been hedging all along. We're mapping the OBBBA exposure across every maternal health startup in the vault.

Was this forwarded to you? Subscribe at pedshealthdispatch.com